IMMUNOLOGICAL ABNORMALITIES IN PATIENTS WHO HAD THE OCULOMUCOCUTANEOUS SYNDROME ASSOCIATED WITH PRACTOLOL THERAPY
Authors:
- P.O. BehanPBP.O. Behan
- W.M.H. BehanWBW.M.H. Behan
- F.J. ZachariasFZF.J. Zacharias
- J.T. NichollsJNJ.T. Nicholls
- 1 November 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 308 (7993) , 984-987
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Practolol and the nephrotic syndrome.BMJ, 1975
- Fibrinous peritonitis: a complication of practolol therapy.BMJ, 1975
- Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.BMJ, 1975
- Untoward effects associated with practolol administration: oculomucocutaneous syndrome.BMJ, 1975
- SCLEROSING PERITONITIS AND PRACTOLOLThe Lancet, 1975
- SCLEROSING PERITONITIS, AN UNUSUAL REACTION TO A β-ADRENERGIC-BLOCKING DRUG (PRACTOLOL)The Lancet, 1974
- Cutaneous and Ocular Reactions to PractololBMJ, 1974
- Systemic Lupus Erythematosus Syndrome Induced by PractololBMJ, 1973
- EXFOLIATIVE DERMATITIS AND PRACTOLOLThe Lancet, 1972
- Measurement of Serum DNA-Binding Activity in Systemic Lupus ErythematosusNew England Journal of Medicine, 1969